News

Calcium+Company Boosts Leadership with New Appointments

Calcium+Company Boosts Leadership with New Appointments

Strategic Appointments at Calcium+Company

Calcium+Company, a prominent health communications firm, has recently made significant changes within its executive team. The company is pleased to announce that James Pietz has joined as the Managing Director of its oncology division, Amino. Meanwhile, Josh Righter has been elevated to the position of Chief Strategy Officer. Both leaders will report directly to Greg Lewis, Group President and Managing Partner.

Growth and Commitment through Leadership

This expansion of leadership reflects Calcium+Company's commitment to growth, particularly in vital sectors such as oncology. By enhancing its strategic capabilities, the company is poised to create a more substantial impact on the market, benefiting clients and their brands.

Focus on Client Needs

CEO Judy Capano emphasizes an unwavering focus on client value drivers, especially in crucial areas like oncology and omnichannel engagement. She states, "We are concentrating on what truly matters to our clients, and this is just the beginning." This dedication is central to the company's mission and vision moving forward.

James Pietz's Vision for Amino

As the new Managing Director, Pietz aims to broaden Amino's scope, introducing a more extensive range of cancer types, therapy classes, and client partnerships. His enhanced framework will capitalize on the established groundwork laid by Amino in the realms of precision insights and engaging storytelling. Pietz is set to lead the charge in crafting targeted engagements that speak directly to patient needs.

The Impact on Patients

Greg Lewis highlights the transformative potential of Pietz’s expertise within the oncology sector, stating, "James's deep knowledge will enable us to touch the lives of many more cancer patients, which drives our mission forward. This impact is a fundamental motivation for all of us here at Calcium+Company." Such commitment underscores the company's purpose to improve patient outcomes through strategic marketing initiatives.

Josh Righter's Strategic Role

In his new capacity as Chief Strategy Officer, Righter is tasked with enhancing the agency's suite of strategic services. His vision encompasses aligning market intelligence with brand planning and marketing communications, fostering a cohesive strategic vision that boosts efficacy and operational efficiency.

Mentoring Future Leaders

Lewis describes Righter as a visionary thinker who inspires those around him, stating, "He will now have the opportunity to spread his talents across various clients and divisions while cultivating the next generation of strategic leaders." This mentorship approach not only elevates current projects but also ensures a pipeline of skilled professionals for the future.

Innovative Marketing Initiatives

Moving forward, Righter will collaborate with Leigh Householder to spearhead the company’s Marketing and Innovation hub. This department is essential in delivering advanced, omnichannel solutions that leverage technology, data, and artificial intelligence for clients at Calcium+Company.

Acknowledging Excellence

Calcium+Company is known for its dedication to excellence and innovation in the healthcare marketing sphere. With a diverse team of over 175 employees spread across various locations, including New York and Philadelphia, the firm excels in strategic, scientific, and creative capabilities. Their recognition as one of the "MM+M Best Places to Work" in a recent year is a testament to their positive workplace culture.

Conclusion: The Future is Bright

The strategic changes happening at Calcium+Company mark an exhilarating chapter for the firm. With new leadership like James Pietz and Josh Righter, the company is well-equipped to navigate the complexities of healthcare marketing, particularly in oncology. This proactive approach is essential as the industry continues to evolve, enabling the company to address diverse patient needs effectively.

Frequently Asked Questions

Who is the new Managing Director of Calcium+Company?

The new Managing Director of Calcium+Company's oncology division, Amino, is James Pietz.

What is Josh Righter's new position at Calcium+Company?

Josh Righter has been promoted to Chief Strategy Officer.

What is the focus of Calcium+Company's growth strategy?

The growth strategy focuses on enhancing services in oncology and improving client engagement through strategic innovation.

What is the mission of Calcium+Company?

The mission is to deliver nourishment in all its forms to clients, brands, communities, and individuals.

How does Calcium+Company support its employees?

Calcium+Company is recognized for offering a positive workplace environment, which has earned it accolades such as being named a top place to work in the industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Growth Projections for the Intravenous Solutions Market

Updated Category News Views 83

Exploring the Intravenous Solutions Market The Intravenous Solutions Market is projected to reach an impressive USD 23.96 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.0% over the forecast period from 2024 to 2031. This robust growth is largely attributed to the increasing elderly population and the rising incidences of malnutrition among them. As...

Continue Reading
Analysts Adjust Price Targets for Progressive After Earnings

Updated Category News Views 151

Progressive Corporation Faces Analysts' Revisions After Q3 Results The Progressive Corporation (NYSE: PGR) recently announced its third quarter earnings, which fell short of analysts' expectations. Analysts and investors alike are closely watching how these results will affect the company's future performance. Disappointing Earnings Report In a recent announcement,...

Continue Reading
Golden Ocean Group's Strategic Merger with CMB.TECH Explained

Updated Category News Views 222

Overview of the Merger Golden Ocean Group Limited (NASDAQ: GOGL) has recently engaged in a strategic collaboration with CMB.TECH NV (NYSE: CMBT) that underscores its ambition to enhance its operational capabilities. This significant merger was initially outlined in a stock exchange announcement, illustrating the companies' plans to join forces for greater efficiency and...

Continue Reading
Investigation Launched Into Zions Bancorp's Securities Practices

Updated Category News Views 219

Investigation of Zions Bancorp by Johnson Fistel, PLLP Johnson Fistel, PLLP, a well-respected law firm specializing in shareholder rights, has embarked on an important investigation regarding Zions Bancorporation, N.A. (NASDAQ: ZION). This inquiry focuses on potential violations of federal securities laws which may have affected investors, particularly regarding...

Continue Reading
Planet Fitness Analysts Anticipate Growth Amid Price Increases

Updated Category News Views 240

Anticipated Growth for Planet Fitness Shares of Planet Fitness Inc (NYSE: PLNT) have shown promising activity in early trading, reflecting a potentially strong outlook. The upcoming fourth-quarter earnings report is capturing market attention, as analysts anticipate robust growth driven by strategic pricing adjustments. Price Adjustments and Market Response The increase...

Continue Reading